Differences in drug utilisation between men and women: A cross-sectional analysis of all dispensed drugs in Sweden

BMJ Open

Volumn 3, Issue 5, 2013, Pages

  Loikas, Desirée ^a,b   Wettermark, Björn ^a,b,c   Von Euler, Mia ^d   Bergman, Ulf ^a,c   Schenck Gustafsson, Karin ^b  

^a Network for Pharmacoepidemiology Foundation   (Sweden)

^b STOCKHOLM COUNTY COUNCIL   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANEMIC AGENT; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; ANTIDIARRHEAL AGENT; ANTIFUNGAL AGENT; ANTIGLAUCOMA AGENT; ANTIGOUT AGENT; ANTIMIGRAINE AGENT; ANTIOBESITY AGENT; ANTIPARKINSON AGENT; ANTIPROTOZOAL AGENT; ANTIVIRUS AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARDIAC GLYCOSIDE; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; IMMUNOSUPPRESSIVE AGENT; MUSCLE RELAXANT AGENT; NEUROLEPTIC AGENT; NOOTROPIC AGENT; OPIATE; PRESCRIPTION DRUG; PSYCHOSTIMULANT AGENT; SPASMOLYTIC AGENT; UNINDEXED DRUG; VASODILATOR AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CROSS-SECTIONAL STUDY; DRUG UTILIZATION; FEMALE; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN; PRESCHOOL CHILD; PREVALENCE; RISK FACTOR; SCHOOL CHILD; SEX DIFFERENCE; SWEDEN;

EID: 84878391605     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2012-002378     Document Type: Article

References (46)

1. Wilson A, McDonald P, Hayes L, et al. Health promotion in the general practice consultation: a minute makes a difference. BMJ 1992;304:227-30.
2. Thorpe KE. The rise in health care spending and what to do about it. Health Aff (Millwood) 2005;24:1436-45.
3. Zuvekas SH, Cohen JW. Prescription drugs and the changing concentration of health care expenditures. Health Aff (Millwood) 2007;26:249-57.
4. Organisation for Economic Co-operation and Development. OECD Health Data 2012-Frequently Requested Data.
5. Wettermark B, Godman B, Andersson K, et al. Recent national and regional drug reforms in Sweden: implications for pharmaceutical companies in Europe. Pharmacoeconomics 2008;26:537-50. (Pubitemid 351871549)
6. World Health Organization. The rational use of drugs. WHO Report of the Conference of Experts, Nairobi. 1985.
7. Campbell CI, Weisner C, Leresche L, et al. Age and gender trends in long-term opioid analgesic use for noncancer pain. Am J Public Health 2010;100:2541-7.
8. Johnell K, Fastbom J. Gender and use of hypnotics or sedatives in old age: a nationwide register-based study. Int J Clin Pharm 2011;33:788-93.
9. Johnston N, Schenck-Gustafsson K, Lagerqvist B. Are we using cardiovascular medications and coronary angiography appropriately in men and women with chest pain? Eur Heart J 2011;32:1331-6.
10. Klungel OH, de Boer A, Paes AH, et al. Sex differences in antihypertensive drug use: determinants of the choice of medication for hypertension. J Hypertens 1998;16:1545-53. (Pubitemid 28470505)
11. Stock SA, Stollenwerk B, Redaelli M, et al. Sex differences in treatment patterns of six chronic diseases: an analysis from the German statutory health insurance. J Womens Health (Larchmt) 2008;17:343-54. (Pubitemid 351457839)
12. World Health Organization (WHO). The selection of essential drugs. Geneva, Switzerland, 1977. Technical Report Series No. 615.
13. Wettermark B, Vlahovic-Palcevski V, Salvesen Blix H, et al. In: Hartzema AG, Tilson HH, Chan KA, eds. Drug Utilization Research. Pharmacoepidemiology and therapeutic risk assessment. Cincinatti, USA: Harwey Whitney Books, 2008:159-95.
14. WHO International Working Group for Drug Statistics Methodology, WHO Collaborating Centre for Drug Statistics Methodology, WHO Collaborating Centre for Drug Utilization Research and Clinical Pharmacological Services. Introduction to drug utilization research. Geneva: World Health Organization, 2003.
15. West SL, Savitz DA, Koch G, et al. Recall accuracy for prescription medications: self-report compared with database information. Am J Epidemiol 1995;142:1103-12.
16. Wettermark B, Hammar N, Fored CM, et al. The new Swedish Prescribed Drug Register-opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf2007;16:726-35. (Pubitemid 47180362)
17. LIF. Swedish Physician's Desk Reference (FASS) Available at: http://www.fass.se (accessed 4 Nov 2011).
18. WHO Collaborating Center for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment, 2012. Oslo, 2011.
19. Statistics Sweden. Population statistics for Sweden 1960-2010. [Befolkningsstatistik i sammandrag 1960-2010]. Stockholm, 2011.
20. Brooks PM. The burden of musculoskeletal disease - a global perspective. Clin Rheumatol 2006;25:778-81. (Pubitemid 44473138)
21. Pinkhasov RM, Wong J, Kashanian J, et al. Are men shortchanged on health? Perspective on health care utilization and health risk behavior in men and women in the United States. Int J Clin Pract 2010;64:475-87.
22. Vaidya V, Partha G, Karmakar M. Gender differences in utilization of preventive care services in the United States. J Womens Health (Larchmt) 2012;21:140-5.
23. Bjoro T, Holmen J, Kruger O, et al. Prevalence of thyroid disease, thyroid dysfunction and thyroid peroxidase antibodies in a large, unselected population. The Health Study of Nord-Trondelag (HUNT). Eur J Endocrinol 2000; 143:639-47.
24. Roy J, Stewart WF. Estimation of age-specific incidence rates from cross-sectional survey data. Stat Med 2010;29:588-96.
25. Gaub M, Carlson CL. Gender differences in ADHD: a meta-analysis and critical review. J Am Acad Child Adolesc Psychiatry 1997;36:1036-45. (Pubitemid 27337654)
26. Baird G, Simonoff E, Pickles A, et al. Prevalence of disorders of the autism spectrum in a population cohort of children in South Thames: the Special Needs and Autism Project (SNAP). Lancet 2006;368:210-15. (Pubitemid 44037796)
27. Dielubanza EJ, Schaeffer AJ. Urinary tract infections in women. Med Clin North Am 2011;95:27-41.
28. Schmiemann G, Kniehl E, Gebhardt K, et al. The diagnosis of urinary tract infection: a systematic review. Dtsch Arztebl Int 2010;107:361-7.
29. Neovius M, Janson A, Rossner S. Prevalence of obesity in Sweden. Obes Rev 2006;7:1-3.
30. Wang Y, Beydoun MA. The obesity epidemic in the United States-gender, age, socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and meta-regression analysis. Epidemiol Rev 2007;29:6-28. (Pubitemid 47229643)
31. Lestner ESH, Sundberg L, Håkansson A, et al. Report specialised obesity treatment [Rapport Specialicerad obesitasbehandling]. Stockholm: Avdelningen för somatisk specialistvård, Hälsooch sjukvårdsförvaltningen, Stockholms läns landsting, Stockholm, 2010.
32. Ivarsson T, Svalander P, Litlere O, et al. Weight concerns, body image, depression and anxiety in Swedish adolescents. Eat Behav 2006;7:161-75.
33. Waaddegaard M, Petersen T. Dieting and desire for weight loss among adolescents in Denmark: a questionnaire survey. Eur Eat Disord Rev 2002;10:329-46. (Pubitemid 35021341)
34. Mackay FJ, Pearce GL, Mann RD. Cough and angiotensin II receptor antagonists: cause or confounding? Br J Clin Pharmacol 1999;47:111-14. (Pubitemid 29043173)
35. Cho L, Hoogwerf B, Huang J, et al. Gender differences in utilization of effective cardiovascular secondary prevention: a Cleveland clinic prevention database study. J Womens Health (Larchmt) 2008;17:515-21. (Pubitemid 351674102)
36. Kapral MK, Degani N, Hall R, et al. Gender differences in stroke care and outcomes in Ontario. Womens Health Issues 2011;21:171-6.
37. Stramba-Badiale M. Women and research on cardiovascular diseases in Europe: a report from the European Heart Health Strategy (EuroHeart) project. Eur Heart J 2010;31:1677-81D.
38. Wettermark B, Persson A, von Euler M. Secondary prevention in a large stroke population: a study of patients' purchase of recommended drugs. Stroke 2008;39:2880-5.
39. Kosek E. Fibromyalgia. In: Schenck-Gustafsson KDP, Pfaff DW, Pisetsky DS, eds. Handbook of clinical gender medicine. Basel: Karger, 2012:164-68.
40. Lip GY, Halperin JL. Improving stroke risk stratification in atrial fibrillation. Am J Med 2010;123:484-8.
41. Di Carlo A, Lamassa M, Baldereschi M, et al. Sex differences in the clinical presentation, resource use, and 3-month outcome of acute stroke in Europe: data from a multicenter multinational hospital-based registry. Stroke 2003;34:1114-19. (Pubitemid 36547498)
42. Friberg L, Rosenqvist M, Lip GY. Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study. Eur Heart J 2012;33:1500-10.
43. Insulander P, Vallin H. Arrhythmias. In: Schenck-Gustafsson KDP, Pfaff DWPisetsky DS, eds. Handbook of clinical gender medicine. Basel: Karger, 2012:229-36.
44. Reid JM, Dai D, Gubitz GJ, et al. Gender differences in stroke examined in a 10-year cohort of patients admitted to a Canadian teaching hospital. Stroke 2008;39:1090-5. (Pubitemid 351440674)
45. Makkar RR, Fromm BS, Steinman RT, et al. Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs. JAMA 1993;270:2590-7. (Pubitemid 23346699)
46. Coughlin SS. Recall bias in epidemiologic studies. J Clin Epidemiol 1990;43:87-91. (Pubitemid 20036970)